Abstract
1. Antagonism, by the selective delta-opioid receptor antagonist naltrindole, of the antinociceptive effects of [D-Pen2, D-Pen5] enkephalin (DPDPE), [D-Ser2, Leu5, Thr6] enkephalin (DSLET) and D-Ala2 deltorphin I (DELT I) has been studied in 25 day old rats. 2. Antinociception was measured by the 50 degrees C tail immersion test following i.p. administration of agonists and/or antagonists. 3. Dose-related antinociception was observed with DPDPE, DSLET and DELT I and ED75 doses were computed (0.66 mg kg-1, 0.65 mg kg-1, 0.032 mg kg-1 respectively) and used for antagonism studies. 4. Naltrindole (0.01 mg kg-1) significantly attenuated the antinociceptive effects of DPDPE and DSLET with 0.1 mg kg-1 producing complete reversal of the effects of the ED75 dose. In contrast, naltrindole at 0.01 and 0.1 mg kg-1 did not alter antinociceptive responses to DELT I. Naltrindole at 1 mg kg-1 significantly attenuated DELT I antinociception. 5. Naloxone (1 mg kg-1) produced equivalent degrees of antagonism of the antinociceptive effects of DPDPE, DSLET and DELT I. ICI 174,864 (1 mg kg-1) also antagonized antinociception with a differential degree of attenuation (DSLET > DPDPE > DELT I). 6. Naltrindole (1 mg kg-1) had no effect on the antinociception induced by the selective mu-agonist alfentanil (60 micrograms kg-1). Naltrindole, naloxone or ICI 174,864 had no effect on nociceptive latencies. 7. The differential antagonism by naltrindole of the effects of three selective delta-agonists suggests delta-receptor heterogeneity.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Calcagnetti D. J., Holtzman S. G. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine. Pharmacol Biochem Behav. 1991 Jan;38(1):185–190. doi: 10.1016/0091-3057(91)90608-5. [DOI] [PubMed] [Google Scholar]
- Erspamer V., Melchiorri P., Falconieri-Erspamer G., Negri L., Corsi R., Severini C., Barra D., Simmaco M., Kreil G. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5188–5192. doi: 10.1073/pnas.86.13.5188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gacel G., Fournie-Zaluski M. C., Roques B. P. D-Tyr--Ser-Gly--Phe--Leu--Thr, a highly preferential ligand for delta-opiate receptors. FEBS Lett. 1980 Sep 8;118(2):245–247. doi: 10.1016/0014-5793(80)80229-8. [DOI] [PubMed] [Google Scholar]
- Galligan J. J., Mosberg H. I., Hurst R., Hruby V. J., Burks T. F. Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids. J Pharmacol Exp Ther. 1984 Jun;229(3):641–648. [PubMed] [Google Scholar]
- Heyman J. S., Mulvaney S. A., Mosberg H. I., Porreca F. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res. 1987 Sep 8;420(1):100–108. doi: 10.1016/0006-8993(87)90244-7. [DOI] [PubMed] [Google Scholar]
- JANSSEN P. A., NIEMEGEERS C. J., DONY J. G. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawl reflex in rats. Arzneimittelforschung. 1963 Jun;13:502–507. [PubMed] [Google Scholar]
- Jiang Q., Takemori A. E., Sultana M., Portoghese P. S., Bowen W. D., Mosberg H. I., Porreca F. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes. J Pharmacol Exp Ther. 1991 Jun;257(3):1069–1075. [PubMed] [Google Scholar]
- Kitchen I., McDowell J., Winder C., Wilson J. M. Low-level lead exposure alters morphine antinociception in neonatal rats. Toxicol Lett. 1984 Aug;22(2):119–123. doi: 10.1016/0378-4274(84)90054-7. [DOI] [PubMed] [Google Scholar]
- Kitchen I., Pinker S. R. Antagonism of swim-stress-induced antinociception by the delta-opioid receptor antagonist naltrindole in adult and young rats. Br J Pharmacol. 1990 Aug;100(4):685–688. doi: 10.1111/j.1476-5381.1990.tb14076.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mosberg H. I., Hurst R., Hruby V. J., Gee K., Yamamura H. I., Galligan J. J., Burks T. F. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Natl Acad Sci U S A. 1983 Oct;80(19):5871–5874. doi: 10.1073/pnas.80.19.5871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paterson S. J., Robson L. E., Kosterlitz H. W. Classification of opioid receptors. Br Med Bull. 1983 Jan;39(1):31–36. doi: 10.1093/oxfordjournals.bmb.a071787. [DOI] [PubMed] [Google Scholar]
- Porreca F., Heyman J. S., Mosberg H. I., Omnaas J. R., Vaught J. L. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. J Pharmacol Exp Ther. 1987 May;241(2):393–400. [PubMed] [Google Scholar]
- Portoghese P. S., Sultana M., Takemori A. E. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol. 1988 Jan 27;146(1):185–186. doi: 10.1016/0014-2999(88)90502-x. [DOI] [PubMed] [Google Scholar]
- Qi J. A., Bowen W. D., Mosberg H. I., Rothman R. B., Porreca F. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site. J Pharmacol Exp Ther. 1990 Nov;255(2):636–641. [PubMed] [Google Scholar]
- Rodriguez R. E., Leighton G., Hill R. G., Hughes J. In vivo evidence for spinal delta-opiate receptor operated antinociception. Neuropeptides. 1986 Oct;8(3):221–241. doi: 10.1016/0143-4179(86)90050-8. [DOI] [PubMed] [Google Scholar]
- Rogers H., Hayes A. G., Birch P. J., Traynor J. R., Lawrence A. J. The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors. J Pharm Pharmacol. 1990 May;42(5):358–359. doi: 10.1111/j.2042-7158.1990.tb05428.x. [DOI] [PubMed] [Google Scholar]
- Sofuoglu M., Portoghese P. S., Takemori A. E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther. 1991 May;257(2):676–680. [PubMed] [Google Scholar]
- Suh H. H., Tseng L. F. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice. Naunyn Schmiedebergs Arch Pharmacol. 1990 Jul;342(1):67–71. doi: 10.1007/BF00178974. [DOI] [PubMed] [Google Scholar]
- Tavani A., Petrillo P., La Regina A., Sbacchi M. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats. J Pharmacol Exp Ther. 1990 Jul;254(1):91–97. [PubMed] [Google Scholar]
- Wild K. D., Vanderah T., Mosberg H. I., Porreca F. Opioid delta receptor subtypes are associated with different potassium channels. Eur J Pharmacol. 1991 Jan 25;193(1):135–136. doi: 10.1016/0014-2999(91)90215-c. [DOI] [PubMed] [Google Scholar]